Future Qichuang Fund
未来启创基金
Future Qichuang Fund (未来启创基金) appears in elsewhere's corpus as a co-investor in two growth-stage deals from 2020–2021: it joined the September 2020 RMB 1.2 billion-plus round for LifeTech Scientific (太美医疗科技) alongside Tencent, Hillhouse Capital, and Yunfeng Capital , and the August 2021 RMB 700 million round for Shukun Technology (数坤科技) alongside Goldman Sachs Asset Management, Sequoia Capital China, and 5Y Capital . The fund is not mentioned in any other capacity—no founding date, team, or AUM is disclosed in the retrieved material.
AI-generated — may contain errors, please verify.
Coverage
September, When Hope Will Break Through Like the Sun | 5Y News Monthly
The big news from last month.
五源资本·5Y Capital Portfolio Company Shukun Technology Announces New 700 Million Yuan Funding Round | 5Y News
Digital human platforms are penetrating deep into healthcare scenarios.
五源资本·Morningside-backed LifeTech Scientific raises over RMB 1.2 billion in new funding round | Light Moments
China's new drug R&D is undergoing a "Cambrian explosion." The industry's underlying infrastructure for pharmaceutical innovation is one of the core sectors we're tracking in healthcare.
五源资本·
